PMCB Other Disclosure
Walker Wayne Remell · SEC Form 4 · Filed Jul 17, 2026
Other
Reported value range
Not reported
Walker Wayne Remell Director
PMCB
PharmaCyte Biotech
PMCB
Transaction date
Mar 31, 2026
Public filing date
Jul 17, 2026
Filing lag
Filed 108 days later
PMCB daily price context
Close on/before transaction
$0.67
Mar 31, 2026
Close before public filing
$0.66
Jul 16, 2026
Return since public filing
-24.08%
Through Aug 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 0 shares
- SEC ownership
- Direct
- Transaction code
- J
- Form
- 4/A
- Filing identifier
- 0001683168-26-005622
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Pharma Cyte Biotech, Inc. PMCB Current | Other | Mar 31, 2026 | Not reported |